Journal News

MCP: Wasp venom causes slow burn in roach brain

John Arnst
Feb. 1, 2019

While most of its parasitic cousins are content to paralyze their prey with a quick thoracic sting, lay an egg in or on the immobilized critter and abandon it to its fate as living larval foodstuff, the jeweled wasp excels in cruelty. Once it has immobilized a roach temporarily with an initial sting to the thorax, the wasp takes up to two minutes to guide two additional stings to the roach’s head ganglia. There, it unleashes a neurochemical cascade that instills hypokinesia, overriding the roach’s instinct to flee with an irresistible drive to laze about and groom. The wasp then grabs the distracted roach by its antennae and guides it to a burrow, where it will endlessly primp until a wasp larva hatches. As the puny parasite’s primary food source, the roach will be kept alive as long as possible, with its least essential organs consumed first.

Emerald wasp drags a cockroach immobilized by the wasp’s venomAn emerald wasp drags a cockroach immobilized by the wasp’s venom into a burrow. A parasitic wasp larva will hatch about three days later and begin to feed on the roach. Deven Dadbhawala/FLICKR For an American cockroach, there is no terror like a jeweled wasp.

While the compound that causes the initial paralysis is mostly the ubiquitous neuroinhibitor GABA, the makeup of the second compound, or compounds, is less understood. To figure out what allows the wasp’s venom to override the roach’s survival instincts for several days, researchers in Michael Adams’ lab at the University of California, Riverside, subjected the enigmatic venom to RNA sequencing and proteomic analysis. They published the details of the venom components, which include hundreds of identified neurotransmitters, hormones and peptide precursors, in the journal Molecular & Cellular Proteomics.

“One wonders if there is a magic bullet that causes this hypokinesia or whether it is a consequence of a lot of different components of the venom working together,” Adams said.

Two of those components are the neurotransmitters tachykinin and corazonin, which have been implicated in behavior and locomotion. When the venom resides inside the acidic environment of the wasp’s venom apparatus, however, they’re present only in their precursor forms.

According to Ryan Arvidson, a postdoctoral researcher in Adams’ lab, one reason for the slow-burning activity of these and other peptides may be their gradual conversion to mature forms as their environmental pH rises to become more neutral within a cockroach.

“There’s some support for the idea that we have this pH-dependent activation of these enzymes that could act like a time-release capsule, slowly generating bioactive peptides over time,” Arvidson said.

Another time-release venom component the researchers found was a ligand for the Toll receptor Spaetzle, which is involved in the activation of NF-kappaB homologs, a protein complex implicated in synaptic transmission in the brain.

“It was interesting because not only was Spaetzle in there, but a serine protease that activates Spaetzle is in the venom, and a serine protease that activates that serine protease is in the venom,” Arvidson said. “It looks like it injects the entire activation cascade of Spaetzle into the brain.”

The functions of all these already-defined neurotransmitters in the wasp venom aren’t exactly clear. In future experiments, Adams and Arvidson hope to explore the mechanisms by which tachykinin, corazonin and Spaetzle interact with the hundreds of other proteins in the venom to suppress the roach’s flight instinct reversibly while leaving intact its ability to walk, swim and fly in a wind tunnel.

“Now that we’ve laid the foundation for what the venom proteome is, we can start asking more hypothesis-based questions,” Arvidson said. “As far as I know, corazonin and another hormone called eclosion hormone are not really implicated in adult insects’ central nervous system activity, specifically with regard to locomotion.

“The wasp venom has pointed us in directions that could answer questions in neuroscience in general, in signaling systems that were previously not understood or underappreciated.”

John Arnst

John Arnst was a science writer for ASBMB Today.

Related articles

From the journals: MCP
Vaishnavi Muralikrishnan
From the journals: MCP
Nivedita Uday Hegdekar & Laurel Oldach
From the journals: May 2019
Gelareh (Abulwerdi) Vinueza, Jonathan Griffin & Kerri Beth Boggs
From the journals: April 2019
Nathalie Gerassimov, Jonathan Griffin, Dawn Hayward & Sasha Mushegian

Join the ASBMB Today mailing list

Sign up to get updates on articles, interviews and events.

Latest in Science

Science highlights or most popular articles

My cat’s coat is mostly white with dark tabby patches. What’s going on?
Science Communication

My cat’s coat is mostly white with dark tabby patches. What’s going on?

Oct. 24, 2021

A researcher uses a tweetorial to figure out the underlying genetics for their cat’s coat.

Dalit scientists face barriers in India’s top science institutes
Diversity

Dalit scientists face barriers in India’s top science institutes

Oct. 23, 2021

Despite decades-old inclusion policies, Dalits are systematically underrepresented in science institutes in India. Why?

‘It goes both ways’
Interview

‘It goes both ways’

Oct. 21, 2021

This year’s theme of “location, location, location” refers to the scenic meeting spot and to a new way of looking at lipids.

From the journals: JLR
Journal News

From the journals: JLR

Oct. 19, 2021

Predicting drug-induced lysosomal fat buildup. Minimizing side effects of atherosclerosis treatment. Finding a key to sepsis diagnosis and treatment. Read about papers on these topics recently published in the Journal of Lipid Research.

A new way of looking at concussions
News

A new way of looking at concussions

Oct. 17, 2021

Emerging research suggests that even mild hits to the head may damage the tiny lymphatic vessels that clear toxic chemicals and cellular debris from the brain.

COVID immunity through infection or vaccination: Are they equal?
News

COVID immunity through infection or vaccination: Are they equal?

Oct. 16, 2021

As scientists argue whether a previous bout of covid offers the same amount of protection as vaccinations, people turn to the courts to decide.